Generic Biologics Are Coming, Commissioner McClellan Tells MBC
Executive Summary
Biogen is understood to be drafting a position statement on generic biologics on behalf of the Massachusetts Biotechnology Council
You may also be interested in...
FDA Will Be Given Cost-Effectiveness Role, Acting Commissioner Predicts
Congress is likely to consider expanding FDA's mission to include direct consideration of economic factors in making approval decisions, Acting Commissioner Lester Crawford, PhD, predicted
FDA Will Be Given Cost-Effectiveness Role, Acting Commissioner Predicts
Congress is likely to consider expanding FDA's mission to include direct consideration of economic factors in making approval decisions, Acting Commissioner Lester Crawford, PhD, predicted
BIO Petition Opposes Generic Insulin, HGH; Asks FDA To Open Public Debate
The Biotechnology Industry Organization is asking FDA to initiate a public comment process on generic biologics before it moves forward in creating approval pathways for generic therapeutic proteins